Home > Journals > Minerva Endocrinologica > Past Issues > Minerva Endocrinologica 2018 September;43(3) > Minerva Endocrinologica 2018 September;43(3):367-76

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

REVIEW   

Minerva Endocrinologica 2018 September;43(3):367-76

DOI: 10.23736/S0391-1977.17.02617-7

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Thyroid dysfunction and non-alcoholic fatty liver disease

Zoe A. EFSTATHIADOU , Marina D. KITA, Stergios A. POLYZOS

Department of Endocrinology, Hippokration General Hospital, Thessaloniki, Greece


PDF


Thyroid hormones are crucial for hepatic lipid and glucose metabolism. Non-alcoholic fatty liver disease (NAFLD), a very common and potentially serious disease of modern society, shares common clinical features with hypothyroidism, such as obesity, insulin resistance and dyslipidemia. Furthermore, in certain studies, increased prevalence of hypothyroidism was observed in patients with NAFLD. However, whether there is a linear relationship between thyroid hormone levels, including values within or in proximity to the reference range and NAFLD incidence and severity remains a contradictory subject in the literature. On the other hand, attempts to treat NAFLD with thyromimetic drugs remain at an early stage. In this review, data derived from observational studies along with evidence on possible treatment with thyroid hormone analogues are presented.


KEY WORDS: Non-alcoholic fatty liver disease - Hypothyroidism - Thyroid diseases

top of page